PERSPECTA

News from every angle

← Back to headlines

ImmunityBio Inc. Stock Performance and Analyst Ratings

Analysts are evaluating ImmunityBio Inc. (IBRX) as a potential momentum stock, assessing its investment appeal.

28 May, 11:00 — 28 May, 11:00
PostShare

Sources

Showing 1 of 1 sources
YahooMostly Factual81d ago

Is ImmunityBio Inc. (IBRX) One of the Best Momentum Stocks to Buy According to Analysts?

Read full article →

Related Stories

Bulgaria Returns 11.6 Tons of Peppers to North Macedonia Due to Pesticides

34m ago

Goldman Sachs to Acquire ETF Provider Neos in $2.3 Billion Deal

40m ago

L3Harris CEO Chris Kubasik Ousted Over Unspecified Conduct

42m ago

KBR Secures $60 Million NATO Contract for Missile Defense System

52m ago